Erythropoiesis-stimulating agent combined with iron supplement

This page covers all Erythropoiesis-stimulating agent combined with iron supplement drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Erythropoietin receptor (EPOR); iron as cofactor for hemoglobin synthesis.

Targets

Erythropoietin receptor (EPOR); iron as cofactor for hemoglobin synthesis

Marketed (1)

• Erythropoietin subcutaneously and Iron intravenously · Catharina Ziekenhuis Eindhoven · Hematology
  Erythropoietin stimulates red blood cell production while intravenous iron provides the essential substrate for hemoglobin synthesis.

Patent intelligence

• erythropoiesis stimulating agent combined with iron supplement patent landscape — aggregated cliff calendar, attackable patents, originator estates